Immunoinformatics design of B and T-cell epitope-based SARS-CoV-2 peptide vaccination

SARS-COV-2 is a virulent respiratory virus, first identified in China (Wuhan) at the end of 2019. Scientists and researchers are trying to find any possible solution to this deadly viral disease. Different drug source agents have been identified, including western medicine, natural products, and tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Muhammad Shehzad, Khan, Ibrar Muhammad, Ahmad, Syed Umair, Rahman, Ishrat, Khan, Muhammad Zahoor, Khan, Muhammad Shah Zeb, Abbas, Zain, Noreen, Shumaila, Liu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846236/
https://www.ncbi.nlm.nih.gov/pubmed/36685569
http://dx.doi.org/10.3389/fimmu.2022.1001430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846236/
https://www.ncbi.nlm.nih.gov/pubmed/36685569
http://dx.doi.org/10.3389/fimmu.2022.1001430

Ejemplares similares